Ironwood Capital Healthcare News

This is selected healthcare news for Ironwood Capital, which is filed under Capital Firms. There are 4 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
11/16/2022 Torigen Pharmaceuticals Announces Completion of $13 Million Capital Raise
... Gaingels, Kema Fund, University of Notre Dame, SoGal Ventures, and UCONN Innovation Fund, LLC participated in the round. New investors in this round also included Ironwood Capital and Advantage Capital. ‚AuOur goal is to create the industry's first oncology toolbox for veterinarians,‚Au said Ashley Kalinauskas, CEO and co ...
PRWeb
5/11/2020 Flux Power Announces Appointment of New Member to the Board of Directors
... NYSE: BDK), and VP Finance at United Technologies Automotive Group (NYSE: UTX). Private equity experience includes : Founding Partner at Ironwood Manufacturing Fund, Senior Advisor at Ironwood Capital, and Partner at Capital Resource Partners. Governance experience as a member of Board of Directors includes: Sturm Ruger & Co (NYSE: RGR), Habco Industries ...
Business Wire
4/16/2020 P2 Science Partners with All Our Kin to Supply Childcare Facilities
... chemistry technologies for converting renewable feedstocks into high-value specialty products. Investors in P2 include BASF Venture Capital, Xeraya Capital, Elm Street Ventures, Connecticut Innovations, Ironwood Capital, HG Ventures and Chanel. The company started up its first manufacturing plant in September of 2018 which produces novel renewable aroma chemicals and ...
PRWeb
5/14/2019 IsoPlexis Completes $25 Million Series C Financing
... 25 million in Series C funding. The round was led by Northpond Ventures and included new strategic investment along with current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and Connecticut Innovations. In 2018 IsoPlexis' novel single-cell immune biomarkers accelerated insights in the rapidly moving field of cancer ...
Business Insider
5/14/2019 IsoPlexis Completes $25 Million Series C Financing
... 25 million in Series C funding. The round was led by Northpond Ventures and included new strategic investment along with current investors Spring Mountain Capital, Ironwood Capital, North Sound Capital, and Connecticut Innovations. In 2018 IsoPlexis' novel single-cell immune biomarkers accelerated insights in the rapidly moving field of cancer ...
PR Newswire